Home › Funds › Polaris Capital Management, LLC › ELV

Polaris Capital Management, LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Polaris Capital Management, LLC reported holding 41,124 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$16.0M, representing 1.68% of its reported portfolio and ranking #23 among its reported holdings. Polaris Capital Management, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)41.12K sh
Reported value held$15.99M
Portfolio Weight1.68%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Polaris Capital Management, LLC's ELV position evolved

Polaris Capital Management, LLC first disclosed a stake in ELV in Q3 2023 at 86,669 shares (US$37.7M). The position peaked in Q4 2023 at 86,269 shares, worth US$40.7M. Across 13 filings, Polaris Capital Management, LLC increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 41,124 shares valued at US$16.0M — a reduction of -2,700 shares quarter over quarter.. Notable position changes include a 37% increase in Q3 2025 (shares rose 9% over the following quarter), a 39% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 86.67K $37.74M New
Q4 2023 86.27K $40.68M Hold
Q1 2024 75.57K $39.19M Reduce
Q2 2024 73.37K $39.76M Reduce
Q3 2024 72.77K $37.84M Reduce
Q4 2024 73.17K $26.99M Add
Q1 2025 65.14K $28.33M Reduce
Q2 2025 61.14K $23.78M Reduce
Q3 2025 83.94K $27.12M Add
Q4 2025 73.94K $25.92M Reduce
Q1 2026 71.64K $20.97M Reduce
Q2 2026 43.82K $16.95M Reduce
Q3 2026 41.12K $15.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Polaris Capital Management, LLC held ELV?

Polaris Capital Management, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Polaris Capital Management, LLC's current position in ELV?

As of Q3 2026, Polaris Capital Management, LLC holds 41.12K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $15.99M, representing 1.68% of its reported portfolio and ranking #23.

Has Polaris Capital Management, LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), Polaris Capital Management, LLC reduced its position in ELV. The position peaked in Q4 2023 at 86.27K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.